NASDAQ · ICU
SeaStar Medical Holding Corporation
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for ICU: Nov 12, 2026
SeaStar Medical Holding Corporation Common Stock is estimated to report earnings on 11/12/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 1 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.95. The reported EPS for the same quarter last year was $-1.3.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.95 | $-0.95 | $-0.95 | 1 |
| Dec 2026 | $-0.89 | $-0.89 | $-0.89 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · The Motley Fool · Fintel- RTTNews · Oct 23, 2:54 AM EDTSeaStar Reports Higher Survival With QUELIMMUNE In Pediatric Kidney Injury Analysis(RTTNews) – SeaStar Medical Holding Corp. (ICU) on Thursday said that critically ill pediatric patients with sepsis-associated acute kidney injury who received QUELIMMUNE (SCD-PED) therapy had significantly higher survival rates than a historical comparison group in the primary a
- RTTNews · Oct 7, 11:38 AM EDTSeaStar Gets FDA Breakthrough Device Designation For SCD In Adult Sepsis; Stock Up(RTTNews) – SeaStar Medical Holding Corp. (ICU), a commercial-stage healthcare company, said the U.S. FDA has granted Breakthrough Device Designation to its Selective Cytopheretic Device (SCD) therapy for treating hyperinflammation in adults with sepsis or a septic condition.
- RTTNews · Oct 5, 9:42 AM EDTSeaStart Medical Raises $3.3 Million Through Warrant Exercises; Stock Down(RTTNews) – Shares of SeaStar Medical Holding Corporation (ICU) are in focus after the company announced an agreement with certain existing warrant holders that is expected to generate approximately $3.3 million in gross proceeds before fees and expenses.
- RTTNews · Oct 2, 2:50 PM EDTBiotech Stocks Move Higher – NIVF +25%, ICU +23%, ATRA +11%, INDP +9%(RTTNews) – Several biotech and healthcare stocks moved sharply higher, driven by company-specific developments including financing activity, regulatory updates and strategic initiatives.
- The Motley Fool · Aug 12, 9:43 PM EDTSeaStar Medical (ICU) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- RTTNews · Aug 10, 2:30 PM EDTSeaStar Medical Gains 13% Ahead Of Q2 Results As Critical Care Pipeline Advances(RTTNews) – Shares of SeaStar Medical Holding Corporation (ICU) are up 13% today as the company gears up to report its second-quarter 2026 financial results on August 12, with investors focused on its commercial progress and clinical development of its Selective Cytopheretic Devi
- RTTNews · Jul 1, 11:16 PM EDTTop Biotech Gainers: CANF Climbs, RGNT Gears Up For Europe Launch, RNAZ, ELTX On Watch(RTTNews) – Today's leading biotech gainers include Can-Fite, following an update from its pancreatic cancer study; SeaStar Medical, driven by improving quarter-over-quarter revenue for its flagship product; and Elicio, which has refined its Phase 3 development strategy for ELI-0
- The Motley Fool · May 13, 5:48 PM EDTSeaStar Medical (ICU) Q1 2026 Earnings Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- RTTNews · Mar 31, 12:11 AM EDTSeaStar Medical Highlights New Positive QUELIMMUNE Data In Pediatric AKI(RTTNews) – SeaStar Medical Holding Corporation (ICU) showcased new positive real-world data from its QUELIMMUNE SAVE Registry, along with new mechanistic insights into its Selective Cytopheretic Device therapy, at the AKI & CRRT 2026 conference.
- RTTNews · Mar 26, 11:26 AM EDTSeaStar Medical Jumps On Q4 Revenue Growth; Exceeds 50% Enrolment In NEUTRALIZE-AKI Pivotal Trial(RTTNews) – SeaStar Medical Holding Corporation, (ICU) a commercial-stage medical device company reported fourth quarter results reflecting a narrower net loss backed by revenue growth. In addition, it also provided business updates on its flagship therapies QUELIMMUNE and NEUTRA
- RTTNews · Mar 5, 9:52 AM ESTSeaStar Medical Completes FDA Enrollment Requirement For SAVE Registry In Pediatric AKI(RTTNews) – SeaStar Medical Holding Corporation (ICU) announced that it has completed the FDA-required enrollment for the SAVE Surveillance Registry, a key post-approval study evaluating the safety of its QUELIMMUNE therapy for children with acute kidney injury due to sepsis or a
- Fintel · Feb 3, 7:17 PM ESTSeaStar Medical Holding (ICU) Price Target Increased by 10.00% to 11.22The average one-year price target for SeaStar Medical Holding (NasdaqCM:ICU) has been revised to $11.22 / share. This is an increase of 10.00% from the prior estimate of $10.20 dated January 11, 2026. The price target is an average of many targets provided by
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for SeaStar Medical Holding Corporation from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.